- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clearpoint Neuro Inc (CLPT)
Track today's live Clearpoint Neuro (CLPT) share price, performance and key data on this page with our current NASDAQ:CLPT stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Clearpoint Neuro share price on the NASDAQ exchange. Use the dropdown to switch exchange for the CLPT share price, head to our technical summary section, which provides analysis on Clearpoint Neuro share price buy/sell indicators using real-time data (or discuss the Clearpoint Neuro (CLPT) stock price today with other investors in the Clearpoint Neuro NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CLPT share price (ISIN: US18507C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Clearpoint Neuro Inc Share Price Today?
The Clearpoint Neuro share price today is 14.90.
What Is the Stock Symbol for Clearpoint Neuro Inc
The stock symbol (or 'ticker') for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:CLPT share price (ISIN: US18507C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Clearpoint Neuro Inc Share Price Today?
The Clearpoint Neuro share price today is 14.90.
What Is the Stock Symbol for Clearpoint Neuro Inc
The stock symbol (or 'ticker') for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.35
14.95
52 wk Range
8.27
30.10
CLPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.3514.95
52 wk Range
8.2730.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
25.67
Upside
+72.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 4 Clearpoint Neuro Inc For: 6 July- Investing.com
Form 4 Clearpoint Neuro Inc For: 2 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 25.67
(+72.26% Upside)
Clearpoint Neuro Inc Earnings Call Summary for Q2/2026
- Clearpoint Neuro Q2 2026 revenue rose 18% YoY to $10.9M but missed estimates by 14.4%; EPS loss of $0.38 exceeded forecast by $0.09.
- Shares plunged 15.5% after-hours to $13 following the dual miss; operating expenses surged 68% in sales/marketing, 64% in G&A.
- Management issued 2026 revenue guidance of $48M-$52M, shifting focus to clinical support and new CAL facility over traditional device sales.
- New California CAL facility could generate $60M+ annually at capacity; first GLP work expected H1 2027 with commercial launches from partners.
- Cash fell to $29.4M from $45.9M year-end 2025; CEO signals pivot to B2B pharma model potentially representing half of future revenue.
Last Updated: 03/08/2026, 22:30
Read Full TranscriptEarnings
Latest Release
03/08/2026
EPS / Forecast
-0.38 / -0.29
Revenue / Forecast
10.9M / 12.73M
Compare CLPT to Peers and Sector
Metrics to compare | CLPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.9x | −10.0x | −0.4x | |
PEG Ratio | 0.27 | −0.15 | 0.00 | |
Price/Book | 41.2x | 4.6x | 2.6x | |
Price / LTM Sales | 10.5x | 2.4x | 3.1x | |
Upside (Analyst Target) | 71.6% | 41.3% | 48.2% | |
Fair Value Upside | Unlock | −4.1% | 5.8% | Unlock |
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Clearpoint Neuro (NASDAQ: CLPT) Share Price Today?
The Clearpoint Neuro stock price today is 14.90 USD.
What Stock Exchange Does Clearpoint Neuro (CLPT) Trade On?
Clearpoint Neuro is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Clearpoint Neuro?
The stock symbol (also called a 'ticker') for Clearpoint Neuro is "CLPT."
What Is the Current Clearpoint Neuro Market Capitalisation?
As of today, Clearpoint Neuro (NASDAQ: CLPT) market cap is 444.45M USD.
What Is Clearpoint Neuro's (CLPT) Earnings Per Share (TTM)?
The Clearpoint Neuro EPS is currently -1.18 (Trailing Twelve Months).
When Is the Next Clearpoint Neuro Earnings Date?
Clearpoint Neuro's next earnings report will be released on 05/11/2026.
Is CLPT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Clearpoint Neuro moving averages and other technical indicators, the daily buy/sell signal for CLPT stock is Strong Buy.
How Many Times Has Clearpoint Neuro Stock Split?
Clearpoint Neuro has split 1 times. (See the CLPT stock split history page for full effective split date and price information.)
How Many Employees Does Clearpoint Neuro Have?
Clearpoint Neuro has 172 employees, based on their latest Companies House report.
What is the current trading status of Clearpoint Neuro (NASDAQ: CLPT)?
As of 11/08/2026, Clearpoint Neuro (CLPT) is trading at a share price of 14.90 USD, with a previous close of 14.57 USD. The stock has fluctuated within a day range of 14.35 USD to 14.95 USD, while its 52-week range spans from 8.27 USD to 30.10 USD.
What Is Clearpoint Neuro (CLPT) Price Target According to Analysts?
The average 12-month price target for Clearpoint Neuro is 25.67 USD, with a high estimate of 30 USD and a low estimate of 22 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +72.26% Upside potential.
What Is the CLPT Premarket Price?
CLPT's last pre-market stock price is 14.63 USD. The pre-market share volume is 110.00, and the stock has decreased by 0.06, or 0.41%.
What Is the CLPT After Hours Price?
CLPT's last after hours stock price is 14.60 USD, the stock has decreased by -0.30, or -2.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.